Literature DB >> 29165263

Bisphosphonates in osteoporosis: NICE and easy?

Nicholas C Harvey1, Eugene McCloskey2, John A Kanis3, Juliet Compston4, Cyrus Cooper5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29165263      PMCID： PMC5724749          DOI： 10.1016/S0140-6736(17)32850-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Authors:  Robert A Adler; Ghada El-Hajj Fuleihan; Douglas C Bauer; Pauline M Camacho; Bart L Clarke; Gregory A Clines; Juliet E Compston; Matthew T Drake; Beatrice J Edwards; Murray J Favus; Susan L Greenspan; Ross McKinney; Robert J Pignolo; Deborah E Sellmeyer
Journal:  J Bone Miner Res       Date:  2016-01       Impact factor: 6.741

2.  Clinical assessment and management of multimorbidity: summary of NICE guidance.

Authors:  Caroline Farmer; Elisabetta Fenu; Norma O'Flynn; Bruce Guthrie
Journal:  BMJ       Date:  2016-09-21

Review 3.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

4.  Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Authors:  J A Kanis; E V McCloskey; H Johansson; O Strom; F Borgstrom; A Oden
Journal:  Osteoporos Int       Date:  2008-08-28       Impact factor: 4.507

Review 5.  Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

Authors:  R Rizzoli; K Akesson; M Bouxsein; J A Kanis; N Napoli; S Papapoulos; J-Y Reginster; C Cooper
Journal:  Osteoporos Int       Date:  2010-11-18       Impact factor: 4.507

6.  UK clinical guideline for the prevention and treatment of osteoporosis.

Authors:  J Compston; A Cooper; C Cooper; N Gittoes; C Gregson; N Harvey; S Hope; J A Kanis; E V McCloskey; K E S Poole; D M Reid; P Selby; F Thompson; A Thurston; N Vine
Journal:  Arch Osteoporos       Date:  2017-04-19       Impact factor: 2.617

7.  The cost-effectiveness of alendronate in the management of osteoporosis.

Authors:  John A Kanis; Judith Adams; Fred Borgström; Cyrus Cooper; Bengt Jönsson; Danielle Preedy; Peter Selby; Juliet Compston
Journal:  Bone       Date:  2007-11-12       Impact factor: 4.398
  7 in total
  7 in total

1.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2018-10-15       Impact factor: 4.507

2.  Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Authors:  P Chotiyarnwong; E V McCloskey; N C Harvey; M Lorentzon; D Prieto-Alhambra; B Abrahamsen; J D Adachi; F Borgström; O Bruyere; J J Carey; P Clark; C Cooper; E M Curtis; E Dennison; M Diaz-Curiel; H P Dimai; D Grigorie; M Hiligsmann; P Khashayar; E M Lewiecki; P Lips; R S Lorenc; S Ortolani; A Papaioannou; S Silverman; M Sosa; P Szulc; K A Ward; N Yoshimura; J A Kanis
Journal:  Arch Osteoporos       Date:  2022-06-28       Impact factor: 2.879

3.  Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss.

Authors:  Yukihiro Kohara; Ryuma Haraguchi; Riko Kitazawa; Yuuki Imai; Sohei Kitazawa
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

Review 4.  State of the art in osteoporosis risk assessment and treatment.

Authors:  J Liu; E M Curtis; C Cooper; N C Harvey
Journal:  J Endocrinol Invest       Date:  2019-04-12       Impact factor: 4.256

Review 5.  General and Specific Considerations as to why Osteoporosis-Related Care Is Often Suboptimal.

Authors:  Elizabeth M Curtis; Stephen Woolford; Claire Holmes; Cyrus Cooper; Nicholas C Harvey
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

Review 6.  Recent advances in prophylactics and treatment of osteoporosis.

Authors:  Marian Szamatowicz; Jacek Szamatowicz
Journal:  Prz Menopauzalny       Date:  2022-06-20

7.  Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.

Authors:  M Chandran; G Ganesan; K B Tan; J-Y Reginster; M Hiligsmann
Journal:  Osteoporos Int       Date:  2020-08-14       Impact factor: 4.507
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.